Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Erectile dysfunction and the "window of curability": a harbinger of cardiovascular events.

Literature DB >> 19181641

Erectile dysfunction and the "window of curability": a harbinger of cardiovascular events.

Martin M Miner.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2009 PMID： 19181641 PMCID： PMC2664578 DOI： 10.1016/S0025-6196(11)60815-X

Source DB: PubMed Journal: Mayo Clin Proc ISSN： 0025-6196 Impact factor: 7.616

× No keyword cloud information.

11 in total

1. Assessment of male sexual function by the Brief Sexual Function Inventory.

Authors: Arnstein Mykletun; Alv A Dahl; Michael P O'Leary; Sophie D Fosså
Journal: BJU Int Date: 2006-02 Impact factor: 5.588

2. Erectile dysfunction and subsequent cardiovascular disease.

Authors: Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; Jeffrey L Probstfield; Carol M Moinpour; Charles A Coltman
Journal: JAMA Date: 2005-12-21 Impact factor: 56.272

Review 3. The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine.

Authors: Graham Jackson; Raymond C Rosen; Robert A Kloner; John B Kostis
Journal: J Sex Med Date: 2006-01 Impact factor: 3.802

4. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Authors: Paul M Ridker; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Journal: N Engl J Med Date: 2008-11-09 Impact factor: 91.245

5. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Authors: Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; Shona J Livingstone; Margaret J Thomason; Michael I Mackness; Valentine Charlton-Menys; John H Fuller
Journal: Lancet Date: 2004 Aug 21-27 Impact factor: 79.321

6. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease.

Authors: Brant A Inman; Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Ajay Nehra; Michael M Lieber; Véronique L Roger; Steven J Jacobsen
Journal: Mayo Clin Proc Date: 2009-02 Impact factor: 7.616

Review 7. Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions.

Authors: Ajay Nehra
Journal: Mayo Clin Proc Date: 2009-02 Impact factor: 7.616

8. Erectile dysfunction predicts coronary heart disease in type 2 diabetes.

Authors: Ronald Ching-Wan Ma; Wing-Yee So; Xilin Yang; Linda Wai-Ling Yu; Alice Pik-Shan Kong; Gary Tin-Choi Ko; Chun-Chung Chow; Clive Stewart Cockram; Juliana Chung-Ngor Chan; Peter Chun-Yip Tong
Journal: J Am Coll Cardiol Date: 2008-05-27 Impact factor: 24.094

9. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors.

Authors: Carmine Gazzaruso; Sebastiano B Solerte; Arturo Pujia; Adriana Coppola; Monia Vezzoli; Fabrizio Salvucci; Cinzia Valenti; Andrea Giustina; Adriana Garzaniti
Journal: J Am Coll Cardiol Date: 2008-05-27 Impact factor: 24.094